{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:42:38Z","timestamp":1791650558275,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.urolonc.2022.01.014","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T07:49:42Z","timestamp":1646034582000},"page":"243-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["The impact of lymphovascular invasion in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma: An extensive updated systematic review and meta-analysis"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8644-2445","authenticated-orcid":false,"given":"Judith","family":"Stangl-Kremser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5973-789X","authenticated-orcid":false,"given":"Antonio Andrea","family":"Grosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Comperat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1885-4808","authenticated-orcid":false,"given":"Fabrizio","family":"Di Maida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Montironi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mesut","family":"Remzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Pradere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Albisinni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Roupret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6627-6179","authenticated-orcid":false,"given":"Shahrokh Francois","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Minervini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy Yuen-Chun","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Moschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5981-3514","authenticated-orcid":false,"given":"Alessia","family":"Cimadamore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9070-5706","authenticated-orcid":false,"given":"Andrea","family":"Mari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.urolonc.2022.01.014_bib0001","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.urolonc.2022.01.014_bib0002","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cncr.24135","article-title":"Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration","volume":"115","author":"Margulis","year":"2009","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.urolonc.2022.01.014_bib0003","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.eururo.2020.05.039","article-title":"Molecular characterization of upper tract urothelial carcinoma in the era of next-generation sequencing: A Systematic Review of the Current Literature","volume":"78","author":"Hassler","year":"2020","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2022.01.014_bib0004","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3390\/genes12030333","article-title":"Current knowledge on genomic profiling of upper tract urothelial carcinoma","volume":"12","author":"De Lorenzis","year":"2021","journal-title":"Genes"},{"issue":"2","key":"10.1016\/j.urolonc.2022.01.014_bib0005","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.urology.2009.10.004","article-title":"A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma","volume":"75","author":"Jeldres","year":"2010","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.urolonc.2022.01.014_bib0006","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2012.02.030","article-title":"Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature","volume":"62","author":"Lughezzani","year":"2012","journal-title":"Eur Urol"},{"issue":"18","key":"10.1016\/j.urolonc.2022.01.014_bib0007","first-page":"3291","article-title":"Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients","volume":"45","author":"Lughezzani","year":"2009","journal-title":"Eur J Cancer Oxf Engl 1990"},{"issue":"5","key":"10.1016\/j.urolonc.2022.01.014_bib0008","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.juro.2012.10.057","article-title":"Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis","volume":"189","author":"Roupr\u00eat","year":"2013","journal-title":"J Urol"},{"issue":"10232","key":"10.1016\/j.urolonc.2022.01.014_bib0009","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(20)30415-3","article-title":"Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial","volume":"395","author":"Birtle","year":"2020","journal-title":"Lancet Lond Engl"},{"issue":"10","key":"10.1016\/j.urolonc.2022.01.014_bib0010","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1136\/jcp.56.10.786","article-title":"Detection of tumour lymphovascular space invasion using dual cytokeratin and CD31 immunohistochemistry","volume":"56","author":"Alexander-Sefre","year":"2003","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.urolonc.2022.01.014_bib0011","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.eururo.2020.05.042","article-title":"European association of urology guidelines on upper urinary Tract urothelial carcinoma: 2020 update","volume":"79","author":"Roupr\u00eat","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2022.01.014_bib0012","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7386140","article-title":"Prognostic value of lymphovascular invasion in upper urinary tract urothelial carcinoma after radical nephroureterectomy: a systematic review and meta-analysis","author":"Liu","year":"2019","journal-title":"Dis Markers"},{"key":"10.1016\/j.urolonc.2022.01.014_bib0013","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fonc.2020.00487","article-title":"The prognostic value of lymphovascular invasion in patients with upper tract urinary carcinoma after surgery: an updated systematic review and meta-analysis","volume":"10","author":"Zhang","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.urolonc.2022.01.014_bib0014","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.urolonc.2022.01.014_bib0015","unstructured":"Ottawa Hospital Research Institute. Accessed May 1, 2021. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"issue":"2","key":"10.1016\/j.urolonc.2022.01.014_bib0016","doi-asserted-by":"crossref","first-page":"132.e13","DOI":"10.1016\/j.urolonc.2020.08.008","article-title":"Association between lymphovascular invasion and oncological outcome in node-negative upper tract urothelial carcinoma with different stage","volume":"39","author":"Chen","year":"2021","journal-title":"Urol Oncol"},{"issue":"16","key":"10.1016\/j.urolonc.2022.01.014_bib0017","doi-asserted-by":"crossref","first-page":"377","DOI":"10.21037\/atm.2019.07.31","article-title":"Impact of squamous differentiation on intravesical recurrence and prognosis of patients with upper tract urothelial carcinoma","volume":"7","author":"Yu","year":"2019","journal-title":"Ann Transl Med"},{"issue":"2","key":"10.1016\/j.urolonc.2022.01.014_bib0018","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1245\/s10434-018-6942-3","article-title":"Combination of the preoperative systemic immune-inflammation index andmonocyte-lymphocyte ratio as a novel prognostic factor in patients with upper-tract urothelial carcinoma","volume":"26","author":"Jan","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.urolonc.2022.01.014_bib0019","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317710822","article-title":"Impact of tumor architecture on disease recurrence and cancer-specific mortality of upper tract urothelial carcinoma treated with radical nephroureterectomy","volume":"39","author":"Fan","year":"2017","journal-title":"Tumour Biol J Int Soc Oncodevelopmental Biol Med"},{"issue":"22","key":"10.1016\/j.urolonc.2022.01.014_bib0020","doi-asserted-by":"crossref","first-page":"36761","DOI":"10.18632\/oncotarget.13611","article-title":"Prognostic value of preoperative plasma fibrinogen level and platelet-to-lymphocyte ratio (F-PLR) in patients with localized upper tract urothelial carcinoma","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.urolonc.2022.01.014_bib0021","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.urolonc.2019.11.010","article-title":"PTRF independently predicts progression and survival in multiracial upper tract urothelial carcinoma following radical nephroureterectomy","volume":"38","author":"Yeh","year":"2020","journal-title":"Urol Oncol"},{"issue":"8","key":"10.1016\/j.urolonc.2022.01.014_bib0022","doi-asserted-by":"crossref","first-page":"685.e17","DOI":"10.1016\/j.urolonc.2020.03.030","article-title":"The expression of urokinase-type plasminogen activator system in upper tract urothelial carcinoma and its prognostic value after radical nephroureterectomy","volume":"38","author":"Abufaraj","year":"2020","journal-title":"Urol Oncol"},{"issue":"10","key":"10.1016\/j.urolonc.2022.01.014_bib0023","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.urolonc.2019.05.021","article-title":"The role of adjuvant radiotherapy after surgery for upper and lower urinary tract urothelial carcinoma: a systematic review","volume":"37","author":"Iwata","year":"2019","journal-title":"Urol Oncol"},{"issue":"5","key":"10.1016\/j.urolonc.2022.01.014_bib0024","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.eururo.2020.07.003","article-title":"Neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma: a 2020 systematic review and meta-analysis, and future perspectives on systemic therapy","volume":"79","author":"Leow","year":"2021","journal-title":"Eur Urol"},{"issue":"12","key":"10.1016\/j.urolonc.2022.01.014_bib0025","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1002\/cncr.25043","article-title":"Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy","volume":"116","author":"Lane","year":"2010","journal-title":"Cancer"},{"issue":"4 Pt 1","key":"10.1016\/j.urolonc.2022.01.014_bib0026","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/01.ju.0000137910.38441.8a","article-title":"Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter","volume":"172","author":"Czito","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2022.01.014_bib0027","unstructured":"Bristol-Myers Squibb. A phase 3 randomized, double-blind, multi-center study of adjuvant nivolumab versus placebo in subjects with high risk invasive urothelial carcinoma (CheckMate 274: CHECKpoint pathway and NivoluMAb Clinical Trial Evaluation 274). Clinicaltrials.gov; 2020. Accessed April 29, 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02632409"},{"key":"10.1016\/j.urolonc.2022.01.014_bib0028","unstructured":"National Cancer Institute (NCI). Phase III Randomized Adjuvant Study of Pembrolizumab in Muscle InvaSive and Locally Advanced Urothelial CaRcinoma (AMBASSADOR) Versus Observation. clinicaltrials.gov; 2021. Acces sed April 29, 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03244384"},{"issue":"4","key":"10.1016\/j.urolonc.2022.01.014_bib0029","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2008.17.2361","article-title":"Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma","volume":"27","author":"Kikuchi","year":"2009","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2022.01.014_bib0030","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.eururo.2009.12.029","article-title":"Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study","volume":"57","author":"Novara","year":"2010","journal-title":"Eur Urol"},{"issue":"16","key":"10.1016\/j.urolonc.2022.01.014_bib0031","doi-asserted-by":"crossref","first-page":"8037","DOI":"10.1158\/0008-5472.CAN-06-0728","article-title":"Real-time imaging of lymphogenic metastasis in orthotopic human breast cancer","volume":"66","author":"Dadiani","year":"2006","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.urolonc.2022.01.014_bib0032","doi-asserted-by":"crossref","first-page":"812","DOI":"10.4161\/cc.5.8.2646","article-title":"Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide?","volume":"5","author":"Wong","year":"2006","journal-title":"Cell Cycle Georget Tex"},{"issue":"1","key":"10.1016\/j.urolonc.2022.01.014_bib0033","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00441-003-0748-7","article-title":"Lymphangiogenesis and tumor metastasis","volume":"314","author":"Pepper","year":"2003","journal-title":"Cell Tissue Res"},{"issue":"6","key":"10.1016\/j.urolonc.2022.01.014_bib0034","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1365-2559.2010.03723.x","article-title":"Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumour stromal mononuclear inflammatory cells and those at the invasive front of breast carcinomas","volume":"57","author":"Gonz\u00e1lez","year":"2010","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.urolonc.2022.01.014_bib0035","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1245\/s10434-014-4103-x","article-title":"Prognostic significance of lymphovascular invasion in upper urinary tract urothelial carcinoma is influenced by tumor location","volume":"22","author":"Lee","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.urolonc.2022.01.014_bib0036","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.eururo.2017.05.048","article-title":"Comprehensive genomic characterization of upper tract urothelial carcinoma","volume":"72","author":"Moss","year":"2017","journal-title":"Eur Urol"},{"issue":"20","key":"10.1016\/j.urolonc.2022.01.014_bib0037","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.3748\/wjg.v25.i20.2489","article-title":"Prognostic significance of lymphovascular invasion in colorectal cancer and its association with genomic alterations","volume":"25","author":"Jiang","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.urolonc.2022.01.014_bib0038","doi-asserted-by":"crossref","unstructured":"Takahashi H, Katsuta E, Yan L, Tokumaru Y, Katz MHG, Takabe K. Transcriptomic profile of lymphovascular invasion, a known risk factor of pancreatic ductal adenocarcinoma metastasis. Cancers. 2020;12(8). doi:10.3390\/cancers12082033","DOI":"10.3390\/cancers12082033"},{"issue":"12","key":"10.1016\/j.urolonc.2022.01.014_bib0039","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/s41416-019-0486-6","article-title":"A key genomic subtype associated with lymphovascular invasion in invasive breast cancer","volume":"120","author":"Kurozumi","year":"2019","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.urolonc.2022.01.014_bib0040","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1590\/s1677-5538.ibju.2017.0204","article-title":"Tissue-based molecular markers in upper tract urothelial carcinoma and their prognostic implications","volume":"44","author":"Favaretto","year":"2018","journal-title":"Int Braz J Urol Off J Braz Soc Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2022.01.014_bib0041","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cancergen.2012.04.008","article-title":"DNA copy number aberrations associated with lymphovascular invasion in upper urinary tract urothelial carcinoma","volume":"205","author":"Misumi","year":"2012","journal-title":"Cancer Genet"},{"issue":"3","key":"10.1016\/j.urolonc.2022.01.014_bib0042","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00345-016-1928-x","article-title":"Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)","volume":"35","author":"Soria","year":"2017","journal-title":"World J Urol"},{"issue":"7","key":"10.1016\/j.urolonc.2022.01.014_bib0043","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1464-410X.2010.09675.x","article-title":"Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA","volume":"107","author":"Raman","year":"2011","journal-title":"BJU Int"},{"issue":"8 Pt 2","key":"10.1016\/j.urolonc.2022.01.014_bib0044","doi-asserted-by":"crossref","first-page":"E304","DOI":"10.1111\/j.1464-410X.2011.10188.x","article-title":"Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study","volume":"108","author":"Matsumoto","year":"2011","journal-title":"BJU Int"},{"issue":"15_suppl","key":"10.1016\/j.urolonc.2022.01.014_bib0045","doi-asserted-by":"crossref","first-page":"e22141","DOI":"10.1200\/JCO.2018.36.15_suppl.e22141","article-title":"Factors associated with delayed diagnosis and treatment in patients with cancer","volume":"36","author":"Okten","year":"2018","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.urolonc.2022.01.014_bib0046","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/PAS.0000000000001141","article-title":"Universal lynch syndrome screening should be performed in all upper tract urothelial carcinomas","volume":"42","author":"Ju","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2022.01.014_bib0047","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.urology.2016.07.036","article-title":"Prognostic factors of overall survival in upper urinary tract carcinoma: a systematic review and meta-analysis","volume":"100","author":"Petrelli","year":"2017","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.urolonc.2022.01.014_bib0048","doi-asserted-by":"crossref","DOI":"10.1186\/s12957-020-01877-w","article-title":"Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma","volume":"18","author":"Li","year":"2020","journal-title":"World J Surg Oncol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143922000321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143922000321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:24:20Z","timestamp":1761042260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143922000321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1078143922000321"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2022.01.014","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of lymphovascular invasion in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma: An extensive updated systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2022.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}